Pharmacologic inhibition of ARF6 remarkably alleviated septic AKI as evidenced by markedly mitigated renal morphologic damage, decreased CLP upregulated levels of SCr and BUN, and lowered mRNA expression of KIM1 and NGAL in injured kidneys (Figure 10A-E). Here, HAVCR1 is linked to acute kidney injury.